Literature DB >> 34253279

Duration of Mydriasis Produced by 0.5% and 1% Tropicamide in Sprague-Dawley Rats.

Stephanie A Pumphrey1, Yoonjin Moon2, Jenelle M Francis3, Misty J Williams-Fritze4, David Lee-Parritz2.   

Abstract

Ophthalmic examination (OE) is a common part of preclinical studies. Pupillary dilation to facilitate OE may affect results of other planned testing. The purpose of this study was to determine the duration of mydriasis produced by commercially available 0.5% and 1% tropicamide in ophthalmologically normal albino rats. Twelve female Sprague-Dawley rats were used. A single drop of 1% tropicamide was applied to one eye of each rat. A single drop of balanced salt solution (BSS) was applied to the contralateral eye. Measurements of pupillary diameter (PD) were obtained using a digital caliper at 0, 20, 40, 60, 120, 180, 240, 300, and 360 min after application. After a 3-wk washout period, the procedure was repeated using 0.5% tropicamide. Pupillary dilation sufficient to allow posterior segment evaluation was achieved with 0.5% and 1% tropicamide. Maximum PD after treatment with 0.5% tropicamide was 4.17 ± 0.22 mm at 40 min; maximum PD after treatment with 1% tropicamide was not significantly different (4.28 mm at both 20 and 40 min (±0.43 mm and 0.23 mm, respectively)). Mean PD remained above 3.5 mm in treated eyes for 60 min. In eyes treated with 0.5% tropicamide, mean PD was significantly different from baseline mean PD for that eye up to 300 min. In eyes treated with 1% tropicamide, mean PD was significantly different than baseline mean PD for that eye at all timepoints. Both concentrations of tropicamide produced a transient mild to moderate mydriasis in the contralateral eye. Duration of action is at least 5 h for 0.5% tropicamide and 6 h for 1% tropicamide. Results of this study support use of 0.5% tropicamide for OE in albino rats, with administration performed no more than 60 min prior to examination.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34253279      PMCID: PMC8603368          DOI: 10.30802/AALAS-JAALAS-21-000013

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  9 in total

1.  Efficacy assessment of various anticholinergic agents against topical sarin-induced miosis and visual impairment in rats.

Authors:  Ariel Gore; Rachel Brandeis; Inbal Egoz; David Peri; Joseph Turetz; Eugenia Bloch-Shilderman
Journal:  Toxicol Sci       Date:  2012-01-12       Impact factor: 4.849

2.  Pupillary function test in rat: Establishment of imaging setup and pharmacological validation within modified Irwin test.

Authors:  H M Himmel; T M Eriksson Faelker
Journal:  J Pharmacol Toxicol Methods       Date:  2019-05-28       Impact factor: 1.950

3.  The functional observational battery and modified Irwin test as global neurobehavioral assessments in the rat: Pharmacological validation data and a comparison of methods.

Authors:  William S Redfern; Angela Dymond; Isobel Strang; Sharon Storey; Claire Grant; Louise Marks; Claire Barnard; Clive Heys; Katherine Moyser; Katherine Greenwood; Des Cobey; Nick Moore; Natasha A Karp; Helen Prior
Journal:  J Pharmacol Toxicol Methods       Date:  2019-05-27       Impact factor: 1.950

4.  Insulin and tropicamide accumulate in the contralateral, untreated eye of rats following ipsilateral topical administration by a mechanism that does not involve systemic uptake.

Authors:  Georgia Patsiopoulos; Vincent Lam; Stephen Lake; Steven B Koevary
Journal:  Optometry       Date:  2003-04

5.  Enhancement of the mydriatic response to tropicamide by bioadhesive polymers.

Authors:  R Herrero-Vanrell; A Fernandez-Carballido; G Frutos; R Cadórniga
Journal:  J Ocul Pharmacol Ther       Date:  2000-10       Impact factor: 2.671

6.  Short acting soft mydriatics.

Authors:  R H Hammer; W Wu; J S Sastry; N Bodor
Journal:  Curr Eye Res       Date:  1991-06       Impact factor: 2.424

7.  Retinal damage in pigmented and albino rats exposed to low levels of cyclic light following a single mydriatic treatment.

Authors:  R A Williams; A G Howard; T P Williams
Journal:  Curr Eye Res       Date:  1985-02       Impact factor: 2.424

Review 8.  Vision in laboratory rodents-Tools to measure it and implications for behavioral research.

Authors:  Henri Leinonen; Heikki Tanila
Journal:  Behav Brain Res       Date:  2017-07-29       Impact factor: 3.332

9.  Establishment of an In Vitro-In Vivo Correlation for Melanin Binding and the Extension of the Ocular Half-Life of Small-Molecule Drugs.

Authors:  Paulina Jakubiak; Carina Cantrill; Arto Urtti; Rubén Alvarez-Sánchez
Journal:  Mol Pharm       Date:  2019-11-12       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.